For the quarter ending 2025-09-30, MNOV made $123,319 in revenue. -$3,049,805 in net income. Net profit margin of -2473.10%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 123,319 | 134,599 | - | - |
| Costs of services | 115,272 | 116,349 | - | - |
| Research, development and patents | 1,582,975 | 2,188,652 | 1,839,802 | 1,859,400 |
| General and administrative | 1,806,070 | 1,436,690 | 1,362,708 | 1,449,728 |
| Total operating expenses | 3,504,317 | 3,741,691 | 3,202,510 | 3,309,128 |
| Operating loss | -3,380,998 | -3,607,092 | -3,202,510 | -3,309,128 |
| Interest income | 340,850 | 324,955 | 336,111 | 447,847 |
| Other income (expense), net | -10,225 | 952 | 2,279 | 9,102 |
| Net loss | -3,050,373 | -3,281,185 | -2,864,120 | -2,852,179 |
| Foreign currency translation adjustments | 568 | 2,681 | 5,102 | 7,724 |
| Comprehensive loss | -3,049,805 | -3,278,504 | -2,859,018 | -2,844,455 |
| Earnings per share, basic | -0.06 | -0.07 | -0.06 | -0.06 |
| Earnings per share, diluted, total | -0.06 | -0.07 | -0.06 | -0.06 |
| Weighted average number of shares outstanding, basic, total | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 |
| Weighted average number of shares outstanding, diluted, total | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 |
MEDICINOVA INC (MNOV)
MEDICINOVA INC (MNOV)